Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$576K Sell
9,165
-210
-2% -$14.6K 0.05% 335
2025
Q4
$622K Buy
9,375
+1,449
+18% +$93.7K 0.06% 265
2025
Q3
$533K Buy
7,926
+194
+3% +$15.4K 0.05% 293
2025
Q2
$675K Buy
+7,732
New +$606K 0.07% 230
2022
Q1
Sell
-2,064
Closed -$277K 118
2021
Q4
$277K Buy
+2,064
New +$297K 0.08% 74

Other funds holding DXCM

Inspire Advisors's DXCM Position: Q1 2026 in Review

Inspire Advisors reduced its DexCom (DXCM) stake by 2.2% in Q1 2026, selling an estimated $14.6K and leaving 9,165 shares worth $576K. The position accounts for 0.05% of the portfolio, ranked #335.

Inspire Advisors first reported a position in DXCM in Q4 2021 and has held it in 5 quarters since. The position peaked at $675K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Inspire Advisors held 9,165 shares of DexCom worth $576K as of Q1 2026.
  • Inspire Advisors sold 210 DexCom shares in Q1 2026, an estimated $14.6K.
  • DexCom made up 0.05% of Inspire Advisors's portfolio in Q1 2026, its #335 holding.
  • Inspire Advisors first reported a position in DexCom in Q4 2021 and has held it in 5 quarters since.
  • Inspire Advisors's DexCom position peaked at $675K in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Inspire Advisors's 13F filing for Q1 2026, filed 15 May 2026.